GE Healthcare is the lead sponsor of 12 current clinical trials in our USA, UK, China and EU (CTIS) registers. 7 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Gadobutrol. The most-studied condition is Monitoring.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
NCT07219238 · Colorectal Cancer, Gastric Cancers, Ovarian Cancers
|
Phase 2/3 | Recruiting | 2026-10 | USA |
|
A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients
NCT07472491 · Known or Highly Suspected Central Nervous System (CNS) Lesion, Known or Highly Suspected Body (Excluding CNS) Lesion
Drug: Gadobutrol |
Phase 2/3 | Recruiting | 2026-04 | USA |
|
A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
NCT04604782 · ClinicalTrials.gov ↗ · Myocardial Ischemia, Coronary Artery Disease
|
Phase 1/2 | Recruiting | 2021-05 | UK |
|
Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging
NCT06639828 · ClinicalTrials.gov ↗ · Focal Liver Lesions
|
Phase 4 | Recruiting | 2025-01 | UK |
|
Data Collection of New Spectral CT Imaging Method
NCT07661706 · ClinicalTrials.gov ↗ · Computed Tomography
|
Observational | Recruiting | 2025-12 | USA |
|
NMT EasyFit Sensor and Cable
NCT07394140 · ClinicalTrials.gov ↗ · Neuromuscular Blockade Monitoring, NMT
|
Not applicable | Recruiting | 2026-06 | USA |
|
Clinical Performance Evaluation of a Diagnostic Ultrasound System
NCT07066449 · ClinicalTrials.gov ↗ · Echocardiography
|
Observational | Recruiting | 2025-08 | China |
|
Portrait Mobile Monitoring Solution V2.0 External Evaluation
NCT07309809 · Monitoring
|
Not applicable | Not yet open | 2026-07 | UK |
|
SpO2 Infant and Pediatric Study
NCT07615738 · SpO2 (Peripheral Oxygen Saturation) Measurement Validation, SpO2
|
Not applicable | Not yet open | 2026-06 | USA |
|
Point of Care Lung Ultrasound Examination in Patients With Shortness of Breath
NCT07046234 · ClinicalTrials.gov ↗ · Lung Disease, Lung Ultrasound
|
Not applicable | By invitation | 2025-08 | USA |
|
GSI Cardiac on Revolution Apex - US
NCT06702917 · ClinicalTrials.gov ↗ · Coronary Computed Tomographic Angiography, Myocardial Infarction (MI), Cardiac Catheterization
|
Observational | Active, closed | 2025-09 | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Authorised or ongoing trials in the EU Clinical Trials Information System with GE Healthcare as sponsor. Some are the same study as a ClinicalTrials.gov record above; the two registries share no common ID. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Countries |
|---|---|---|---|
|
A Phase 2/3, Multicenter, Open-Label, Non-Randomized Study to Evaluate Diagnostic Performance of GEH300079 (68Ga) Injection Positron-Emission Tomography (PET)/Computed Tomography (CT) for Detection of Peritoneal Carcinomatosis (PC) in Patients with Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
2024-519384-18-00 · CTIS ↗ · Diagnosis
|
Phase 3 | Ongoing | Sweden, Netherlands |
Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 7 | 4 |
| Clinical trials in UK | 3 | 2 |
| Clinical trials in China | 1 | 1 |
| EU register (CTIS) | 1 | — |
A trial with sites in more than one country appears in each of those registers.
GE Healthcare is the lead sponsor of 11 current trials on ClinicalTrials.gov in our USA, UK and China registers, and 1 authorised or ongoing trial in the EU register (CTIS), as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 7 of its 11 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Its current trials name 1 drug or biological as interventions. The most frequent are Gadobutrol (1). The number in brackets is how many of its trials name each drug.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.